For decades Cochlear, CSL and ResMed could do no wrong. Those days are over, and a battery of issues has investors ...

A major Australian medical company has suffered a $4.4b wipeout after slashing its earnings forecast, which drove its share price to a 10-year low.

The hearing implant maker’s share price cratered to the lowest level since April 2016 after it warned that softer global sales would hit its bottom line.

Cuts to Medicaid legislated by Trump’s One Big Beautiful Bill Act have crippled Cochlear’s American business by restricting coverage for hearing implants. The ASX company said it expected underlying ...

LONE TREE, Colo., March 3, 2025 /PRNewswire/ — In celebration of World Hearing Day, Cochlear, the global leader in implantable hearing solutions, is proud to announce that it has been named the number ...

SYDNEY >> Hearing impaired children in Japan’s coastal city of Shizuoka will from next year be able to listen, learn and speak better thanks to an A$6.5 million ($4.4 million) programme funded by the ...

SBS Finance Editor Ricardo Gonçalves speaks with Cochlear CEO Dig Howitt after the group's full-year results annoucement about the future of implants, while Stephanie Youssef discusses the role of EVs ...